Mangoceuticals (MGRX) Revenue (2023 - 2026)

Mangoceuticals (MGRX) reported Revenue of $67864.0 for Q1 2026, down 37.91% on a YoY basis from $109306.0 in Q1 2025, and down 28.08% sequentially from $94360.0 in Q4 2025.

Mangoceuticals (MGRX) Revenue (2023 - 2026) Analysis & Trends

Mangoceuticals (MGRX) has 4 years of Revenue data on file, last reported at $67864.0 in Q1 2026.

  • For the quarter ending Q1 2026, Revenue fell 37.91% year-over-year to $67864.0; the trailing twelve-month figure through Mar 2026 stood at $414579.0 (down 18.88% YoY), and the FY2025 full-year result was $456021.0, down 25.96% from the prior year.
  • Revenue retreated to $67864.0 in Q1 2026, from $94360.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $245160.0 in Q3 2023 to a low of $67864.0 in Q1 2026.
  • A 4-year average of $143942.4 and a median of $133368.0 in 2024 frame the typical range for Revenue.
  • Peak annual rise in Revenue reached 112.56% in 2024, while the deepest fall reached 56.93% in 2024.
  • Tracing MGRX's Revenue over 4 years: stood at $244374.0 in 2023, then tumbled by 56.93% to $105247.0 in 2024, then decreased by 10.34% to $94360.0 in 2025, then dropped by 28.08% to $67864.0 in 2026.
  • Business Quant data shows MGRX's Revenue at $67864.0 in Q1 2026, $94360.0 in Q4 2025, and $84246.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Veeva Systems 31.81 Bn 24.49 Bn 662.02 Mn 882.95 Mn
2 BrightSpring Health Services 14.76 Bn 13.86 Bn 482.22 Mn 3.61 Bn
3 Healthequity 8.36 Bn 8.10 Bn 256.31 Mn 354.64 Mn
4 Hinge Health 5.91 Bn 5.60 Bn 154.23 Mn 182.31 Mn
5 10x Genomics 5.89 Bn 5.35 Bn 106.18 Mn 150.84 Mn
6 MiniMed 4.45 Bn 4.16 Bn 480.00 Mn 837.00 Mn
7 Waystar Holding 4.41 Bn 4.35 Bn 216.84 Mn 313.87 Mn
8 Doximity 3.93 Bn 3.18 Bn 125.97 Mn 145.37 Mn
9 Privia Health 3.10 Bn 2.68 Bn - 603.85 Mn
10 Mangoceuticals 9.39 Mn 9.20 Mn 29,001.00 67,864.00

Historic Data

Download Data
DateValue
Mar 31, 2026 67,864.00
Dec 31, 2025 94,360.00
Sep 30, 2025 84,246.00
Jun 30, 2025 168,109.00
Mar 31, 2025 109,306.00
Dec 31, 2024 105,247.00
Sep 30, 2024 133,368.00
Jun 30, 2024 163,163.00
Mar 31, 2024 214,095.00
Dec 31, 2023 244,374.00
Sep 30, 2023 245,160.00
Jun 30, 2023 141,237.00
Mar 31, 2023 100,722.00